CPH 0.00% 0.9¢ creso pharma limited

Why wouldn't you buy?, page-12

  1. 837 Posts.
    lightbulb Created with Sketch. 42
    A few significant changes in the legislation regarding general Cannabis usage in some countries will open the floodgates in many others, favouring the early adopter companies. Those would primarily be those with large footprints in Canada and the US, but will benefit ASX listed ones significantly. Could see a doubling of SP yearly for a few years. That is exponential growth beating the XJO achievement of 7% in 2017 by a ridiculous amount.
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.